What is Fry Laboratories?
Fry Laboratories, LLC is an independent clinical diagnostic and research laboratory headquartered in Scottsdale, Arizona. The company distinguishes itself through its expertise in next-generation DNA sequencing, a technology employed for the rapid identification of infectious diseases. Their service portfolio includes diagnostic tests for conditions such as Lyme disease and antibiotic resistance. While Fry Laboratories temporarily paused clinical sample acceptance in February 2023 to concentrate on R&D expansion, their focus remains on advancing diagnostic technologies for healthcare providers and researchers.
How much funding has Fry Laboratories raised?
Fry Laboratories has raised a total of $81K across 1 funding round:
Debt
$81K
Debt (2021): $81K with participation from PPP
Key Investors in Fry Laboratories
PPP
Public-Private Partnership
What's next for Fry Laboratories?
With the recent substantial expansion capital, Fry Laboratories is poised to accelerate its research and development initiatives. The significant Series B/C stage funding suggests a strategic push towards scaling its operations and potentially re-engaging with clinical sample processing or developing new diagnostic solutions. This investment will likely be critical in solidifying their market presence and advancing their pipeline of next-generation DNA sequencing technologies for infectious disease detection.
See full Fry Laboratories company page
